Nanomedical Diagnostics Financing
Nanomedical Diagnostics, Inc., Corporation just had published form D for $1.40 million debt financing. This is a new filing. Nanomedical Diagnostics was able to fundraise $425,000 so far. That is 30.36% of the offering. The total private financing amount was $1.40 million. The offering form was filed on 2016-07-13. The reason for the financing was: unspecified. The fundraising still has about $975,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Nanomedical Diagnostics is based in California. The firm’s business is Other Technology. The form D was filed by Ross Bundy President and Chief Executive Officer. The company was incorporated in 2014. The filler’s address is: 6185 Cornerstone Ct., Suite 110, San Diego, Ca, California, 92121. Ross Bundy is the related person in the form and it has address: 6185 Cornerstone Ct., Suite 110, San Diego, Ca, California, 92121. Link to Nanomedical Diagnostics Filing: 000101968716006923.
Analysis of Nanomedical Diagnostics Offering
On average, startups in the Other Technology sector, sell 85.80% of the total offering amount. Nanomedical Diagnostics sold 30.36% of the offering. The financing is still open. The average fundraising size for companies in the Other Technology industry is $1.54 million. The offering was 72.40% smaller than the average of $1.54 million. Of course this should not be taken as negative. Startups raise funds for different needs and reasons. The minimum investment for this offering was set at $0. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Nanomedical Diagnostics Also
The Form D signed by Ross Bundy might help Nanomedical Diagnostics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.